Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

This study has been completed.
Information provided by:
Orion Corporation, Orion Pharma Identifier:
First received: October 31, 2005
Last updated: June 22, 2007
Last verified: June 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given